• market

  PRIVATE

• industry

  Biotechnology

• website

  triumvira.com

• crunchbase

  triumvira-immunologics-inc

Triumvira Immunologics is a clinical-stage immuno-oncology company focused on developing targeted autologous and allogeneic T cell therapeutics to treat a broad range of patients with cancer. The company's proprietary T cell Antigen Coupler (TAC) technology co-opts the natural biology of T cells to activate and regulate the immune system to fight difficult-to-treat tumors.